Director of Rubius Therapeutics, Inc. (NASDAQ:RUBY), Epstein David R, sells 2,100 shares worth $31,146
According to Rubius Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 09:12 PM, company Director, Epstein David R disclosed selling 2,100 shares at a cost of $14.83. At the time of this transaction (Feb 09), this trade was worth $31,146 in total. As of Feb 09, Epstein David R now owns 4,724,120 shares in total worth about $67,980,086.8.
For the last few recent trades made by Rubius Therapeutics, Inc. (NASDAQ:RUBY) Director, Epstein David R, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 89,233 shares at the rate of $14.88 per share. Total worth of this trade was $1,328,117. Total number of shares owned as of Feb 08 were 4,726,220
- SEC Form 4 filing: Feb 10: Sold 7,404 shares at the rate of $14.79 per share. Total worth of this trade was $109,525. Total number of shares owned as of Feb 10 were 4,716,716
Posted by
George Daniels
on Wednesday February 10 2021, 11:48 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
